Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders

Graphical abstract

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2015-07, Vol.63 (1), p.30-37
Hauptverfasser:	Jensen, Donald, Sherman, Kenneth E, Hézode, Christophe, Pol, Stanislas, Zeuzem, Stefan, de Ledinghen, Victor, Tran, Albert, Elkhashab, Magdy, Younes, Ziad H, Kugelmas, Marcelo, Mauss, Stefan, Everson, Gregory, Luketic, Velimir, Vierling, John, Serfaty, Lawrence, Brunetto, Maurizia, Heo, Jeong, Bernstein, David, McPhee, Fiona, Hennicken, Delphine, Mendez, Patricia, Hughes, Eric, Noviello, Stephanie
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antiviral Agents - administration & dosage Asunaprevir Daclatasvir Direct-acting antiviral DNA, Viral - genetics Drug Administration Schedule Drug Carriers Drug Therapy, Combination Female Follow-Up Studies Gastroenterology and Hepatology Genotype Hepacivirus - genetics Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Humans Imidazoles - administration & dosage Interferon-alpha - administration & dosage Isoquinolines - administration & dosage Male Middle Aged NS5A Null Partial Peginterferon alfa Polyethylene Glycols - administration & dosage Recombinant Proteins - administration & dosage Ribavirin - administration & dosage Sulfonamides - administration & dosage Treatment Outcome Viral Load - genetics Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!